Label Image (Lbl500907589)
Trulicity Injection, Solution
Product Images NDC 50090-7589
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 50 technical images submitted to the FDA as part of the official labeling for Trulicity (NDC 50090-7589). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Logo (Logo)
Qr Code (Qr V1)
Figure (Trulicity Ifu 0point75 Injection Sites Back V1)
Figure (Trulicity Ifu 0point75 Injection Sites Front V1)
Figure (Trulicity Ifu 1point5 Injection Sites Back V1)
Figure (Trulicity Ifu 1point5 Injection Sites Front V1)
Figure (Trulicity Ifu 3mg Injection Sites Back V1)
Figure (Trulicity Ifu 3mg Injection Sites Front V1)
Figure (Trulicity Ifu 4point5mg Injection Sites Back V1)
Figure (Trulicity Ifu 4point5mg Injection Sites Front V1)
Figure (Trulicity Ifu Check V1)
Exclamation (Trulicity Ifu Exclamation V1)
Figure (Trulicity Ifu Expiration Location V2)
Figure (Trulicity Ifu Inspect V1)
Locked (Trulicity Ifu Locked V1)
Figure (Trulicity Ifu Prepare V1)
Figure (Trulicity Ifu Remove V1)
Figure (Trulicity Ifu Sup 0point75 F2 V3)
Figure (Trulicity Ifu Sup 0point75 F3 V3)
Figure (Trulicity Ifu Sup 0point75 F4 V3)
Figure (Trulicity Ifu Sup 0point75 F5 V3)
Figure (Trulicity Ifu Sup 0point75 Pen Parts V3)
This text appears to describe a medical device, possibly a syringe or an injection tool. It includes components such as a top with an injection button, a lock ring, an indicator, a lock/unlock mechanism, a medicine chamber, a bottom or clear base, a needle end, and a base cap. These parts are likely essential for the functionality and safety of the device.*
Figure (Trulicity Ifu Sup 0point75 Pen V3)
Figure (Trulicity Ifu Sup 1point5 F2 V3)
Figure (Trulicity Ifu Sup 1point5 F3 V3)
Figure (Trulicity Ifu Sup 1point5 F4 V3)
Figure (Trulicity Ifu Sup 1point5 F5 V3)
Figure (Trulicity Ifu Sup 1point5 Pen Parts V3)
This is a description of an injection button device. It includes parts like top with a lock ring, indicator, medicine, bottom/clear base, needle, end base cap, and a lock/unlock feature.*
Figure (Trulicity Ifu Sup 1point5 Pen V3)
Figure (Trulicity Ifu Sup 3mg F2 V1)
Figure (Trulicity Ifu Sup 3mg F3 V1)
Figure (Trulicity Ifu Sup 3mg F4 V1)
This text provides instructions on how to determine when an injection is complete. It mentions that the completion of the injection can be identified when the gray plunger is visible. The username displayed at the top is "@sroseconds".*
Figure (Trulicity Ifu Sup 3mg F5 V1)
Figure (Trulicity Ifu Sup 3mg Pen Parts V1)
This description is not readable.*
Figure (Trulicity Ifu Sup 3mg Pen V1)
Figure (Trulicity Ifu Sup 4point5 F2 V1)
Figure (Trulicity Ifu Sup 4point5 F3 V1)
Figure (Trulicity Ifu Sup 4point5 F4 V1)
This text provides guidance on administering an injection. It instructs that the injection is complete when the gray plunger becomes visible.*
Figure (Trulicity Ifu Sup 4point5 F5 V1)
Figure (Trulicity Ifu Sup 4point5 Pen Parts V1)
This text appears to be a description of a medical device, possibly a syringe or injection tool. It mentions features such as "Top MR Injection Button," "LockRing," "Indicator," "LockUnlock," "Medicine," "ClearBase," "Needle," and "BaseCap." The text seems to describe different parts or functions of the medical device. It is likely used for administering medication or injections.*
Figure (Trulicity Ifu Sup 4point5 Pen V1)
Figure (Trulicity Ifu Unfold V1)
Unlocked (Trulicity Ifu Unlock V1)
Figure 1 (Trulicity Pi F1 V2)
This text appears to include various categories related to intrinsic factors affecting certain characteristics or conditions, including weight, age, gender, ethnicity, renal impairment severity, hepatic impairment severity, as well as specific parameters like PK, Ratio, 90%CI, and values such as 0.5, 1.0, 1.5, and 2.0. It seems to be a categorization or classification system for evaluating specific factors and their relationships for analytical or medical purposes.*
Figure 2 (Trulicity Pi F2 V2)
This document appears to provide information on the coadministration of various drugs such as Lisinopril, Metoprolol, Digoxin, Norelgestromin, Ethinylestradiol, Atorvastatin, Metformin, Acetaminophen, S-Warfarin, R-warfarin, and Sitagliptin. The focus seems to be on pharmacokinetic parameters (PK) such as AUC and Cmax, as well as the calculation of ratios with 90% confidence intervals. It may be a study evaluating the impact of coadministration on drug levels and interactions.*
Figure 3 (Trulicity Pi F3 V3)
Figure 4 (Trulicity Pi F4 V3)
This is a graph showing the mean HbA1c levels (%) over a period of weeks post-randomization for three different doses of TRULICITY: 1.5 mg, 3 mg, and 4.5 mg. The HbA1c levels decrease over time for all three doses.*
Figure 5 (Trulicity Pi F5 V2)
This text provides data on LS Mean HbA1 (%) at different time points and includes references to different medications such as TRULIGITY 15mg and Exenaide. The information seems to be related to a study or clinical trial.*
Figure 6 (Trulicity Pi F6 V2)
This is a summary table showing the percentage of patients with an event over a 6-year period in a placebo group and a group treated with Dulaglutide. The hazard ratio (HR) for Dulaglutide compared to placebo is 0.88 with a 95% confidence interval of [0.79, 0.99].*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
